Tissue-Engineered Brain-Mimetic Niches to Model Braintropic Triple-Negative Breast Cancer Metastasis
Tissue Engineering Part C: Methods · 2026
DOI: 10.1177/19373384251404201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering Part C: Methods, 2026. Verfasst von Sam Freeman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Delaware, Newark, Delaware, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Brain Neoplasms, Tissue Engineering, Brain. Die Arbeit nennt 44 Literaturangaben. Gefördert von: national institutes of health, national institute of general medical sciences.
Abstract (Originalsprache)
Brain metastases of triple-negative breast cancer (TNBC) rapidly progress, causing severe neurological decline with a median survival of less than 6 months. This tragic disease is often difficult to identify with sufficient time for treatment and is exacerbated by a lack of effective pharmacological intervention. Replicating the biochemical and mechanical properties of the premetastatic niche in vitro is a critical step in expediting the development of new therapeutics. However, a high-fidelity and reproducible model system is needed. To quantify the influence of a brain-mimetic microenvironment on brain metastatic TNBC, we encapsulated and cultured the TNBC cell line, MDA-MB-231 (P231), and its braintropic subline, MDA-MB-231-BrM2a-831 (BrM2a), in three premetastatic niches: a highly cell-adhesive and highly cell-degradable permissive niche, a highly adhesive but less degradable niche, and a nonadhesive but highly degradable niche. To mimic brain extracellular matrix, we functionalized the adhesive formulations with a brain-mimetic peptide cocktail and compared the cell responses to a “generic” RGDS-functionalization. This suite of conditions allowed us to investigate the influences of integrin-mediated adhesion, cell-mediated degradation, and cell type on the fate of P231s and BrM2as. Our data demonstrate that brain-mimetic adhesion has little to no impact on P231 phenotype, but the BrM2as display reduced viable cell density, reduced proliferation, and a higher proportion of both spherical clusters and spherical individual cells compared with the “generic” RGDS-functionalized niches. This suggests that brain-mimetic adhesion signaling encourages a rounded, less invasive phenotype in BrM2as. Modeling pathological processes usingadvanced, biomimetic in vitro models that better replicate in vivo cell phenotype have the potentialtoenhanceimprove the outcome of preclinical therapeutic testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, University of Delaware, Newark, Delaware, USA.
Förderung
- national institutes of health
- national institute of general medical sciences
Zitieren
APA
Freeman, S., & Slater, J. (2026). Tissue-Engineered Brain-Mimetic Niches to Model Braintropic Triple-Negative Breast Cancer Metastasis. Tissue Engineering Part C: Methods. https://doi.org/10.1177/19373384251404201
Vancouver
Freeman S, Slater J. Tissue-Engineered Brain-Mimetic Niches to Model Braintropic Triple-Negative Breast Cancer Metastasis. Tissue Engineering Part C: Methods. 2026. doi:10.1177/19373384251404201
BibTeX
@article{Freeman2026,
author = {Freeman, Sam and Slater, John},
title = {Tissue-Engineered Brain-Mimetic Niches to Model Braintropic Triple-Negative Breast Cancer Metastasis},
journal = {Tissue Engineering Part C: Methods},
year = {2026},
doi = {10.1177/19373384251404201}
}
EUVIMED